# Asciminib Hydrochloride (Scemblix)

Source: https://ourhealthnetwork.com/drugs/asciminib-hydrochloride
Data: FDA Orange Book and OpenFDA, refreshed periodically

## What is Asciminib Hydrochloride?

Asciminib Hydrochloride (brand name: Scemblix) is a kinase inhibitor. It is prescribed to treat leukemia, myeloid. Across the United States, 133 doctors prescribe Asciminib to approximately 14 Medicare patients.

## Brand names

Scemblix

## Indications

Asciminib Hydrochloride is prescribed for the treatment of leukemia and myeloid.

## Conditions treated

- [Leukemia](https://ourhealthnetwork.com/conditions/leukemia)
- [Myeloid](https://ourhealthnetwork.com/conditions/myeloid)

## Mechanism of action

Asciminib is an ABL/BCR-ABL1 tyrosine kinase inhibitor. Asciminib inhibits the ABL1 kinase activity of the BCR::ABL1 fusion protein, by binding to the ABL myristoyl pocket.

## Drug classification

- Established Pharmacologic Class: kinase inhibitors
- Route of administration: ORAL

## Common side effects

abdominal pain, arthralgia, diarrhea, fatigue, headache, musculoskeletal pain, rash, upper respiratory tract infection

## Sources and disclaimers

- FDA Orange Book and OpenFDA dataset
- This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting, stopping, or changing any medication.

## Related

- [All drugs](https://ourhealthnetwork.com/drugs)
- [Find specialists who prescribe this drug](https://ourhealthnetwork.com/find-doctors)
- [Methodology](https://ourhealthnetwork.com/methodology)